A randomised controlled trial of intravenous versus intramuscular oxytocin in the management of third stage of labor.

Not Applicable

Not yet recruiting

• Conditions: Incidence of postpartum hemorrhage within 24 hours postpartum periods; Hematocrit concentration , change of hematocrit at 24 hr; Prolonged third stage of labor ( > 30 mins ); Oxytocin additional dose, other additional drugs; Blood transfusion; Reproductive Health and Childbirth - Normal pregnancy

• Registration Number: ACTRN12612000624886
• Lead Sponsor: Khon Kaen Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-06-12
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Not yet recruiting
• Sex: Female
• Target Recruitment: 450

Inclusion Criteria

. Singleton pregnancy with spontaneous vertex delivery
. Gestational age at least 34 weeks
. Parity < 5

Exclusion Criteria

. Cesarean section
. High risk postpartum hemorrhage ;
- Pregnancy induced hypertension (PIH) ,
- multifetal pregnancy , polyhydramnios , macrosomia ,
- Placenta previa ,Placental abruption ,Placenta accreta/increta/percreta
- hematologic problems: thrombocytopenia, coagulopathy
- Obesity ( BMI >29 ) ,Previous postpartum hemorrhage
. Previous history of curettage
. Previous manual removal of placenta
. Cardiovascular instability
. Under anesthesia
. Oxytocin hypersensitivity
. Medical problem: Diabetes mellitus (DM) , nephrotic syndrome , renal insufficiency ,sepsis

Study & Design

• Study Type: Interventional
• Study Design: Not specified